AVEO Pharmaceuticals Inc. signed a 12-yearwith BioMed Realty Trust Inc. for 126,000 sq. ft. of office and laboratory space at 650 East Kendall St. in Cambridge, Mass. The property is located in the heart of a biotechnology super-cluster. It is a six-story, 280,000-sq.-ft. research facility supported by six levels of below-grade parking. The building has received Gold LEED certification from the U.S. Green Building Council.
AVEO is a cancer therapeutics company.
“We are pleased to welcome AVEO to 650 East Kendall and Kendall Square, the ideal location for their mission-critical research and clinicalof cancer therapeutics,” said BioMed’s Chairman and CEO Alan D. Gold in a statement. “650 East Kendall was built to the exacting requirements of world-class life science tenants in order to support transformational research, such as AVEO’s new treatments for the medical oncology community and their patients.”